Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01650701 |
|---|---|
| Brief Title: | A Phase 3 Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma (RELEVANCE) |
| First Submitted : | July 24, 2012 |
| First Submitted that Met QC Criteria : | July 24, 2012 |
| First Posted : | July 26, 2012 (Estimate) |
| Last Update Submitted that Met QC Criteria : | March 13, 2024 |
| Last Update Posted : | March 15, 2024 |